UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity

Breast cancer research : BCR, 2015-04, Vol.17 (1), p.57-57, Article 57

2015

Volltextzugriff (PDF)

A heavy metal baseline score predicts outcome in acute myeloid leukemia

American journal of hematology, 2020-04, Vol.95 (4), p.422-434

2020

Volltextzugriff (PDF)

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform

Pharmaceuticals (Basel, Switzerland), 2021-03, Vol.14 (3), p.247

2021

Volltextzugriff (PDF)

Antimitotic and Antiproliferative Activities of Chalcones: Forward Structure–Activity Relationship

Journal of medicinal chemistry, 2008-04, Vol.51 (7), p.2307-2310

2008

Volltextzugriff (PDF)

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy

Frontiers in immunology, 2023-01, Vol.13, p.1011943-1011943

2023

Volltextzugriff (PDF)

Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice

Frontiers in immunology, 2024, Vol.15, p.1368550-1368550

2024

Volltextzugriff (PDF)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

Frontiers in immunology, 2023-05, Vol.14, p.1066402-1066402

2023

Volltextzugriff (PDF)

Characterization of T‐DM1‐resistant breast cancer cells

Pharmacology research & perspectives, 2020-08, Vol.8 (4), p.e00617-n/a

2020

Volltextzugriff (PDF)

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability

Clinical and experimental pharmacology & physiology, 2014-10, Vol.41 (10), p.817-824

2014

Volltextzugriff (PDF)

Structure–activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein

Bioorganic & medicinal chemistry, 2006-10, Vol.14 (20), p.6979-6987

2006

Volltextzugriff (PDF)

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

Frontiers in immunology, 2018-10, Vol.9, p.2100-2100

2018

Volltextzugriff (PDF)

Proof of Concept: Protein Delivery into Human Erythrocytes Using Stable Cavitation

Molecular pharmaceutics, 2022-03, Vol.19 (3), p.929-935

2022

Volltextzugriff (PDF)

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells

BMC cancer, 2010-04, Vol.10 (1), p.135-135, Article 135

2010

Volltextzugriff (PDF)

ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells

Experimental cell research, 2007-02, Vol.313 (3), p.473-485

2007

Volltextzugriff (PDF)

IN VIVO SYNGENEIC TUMOR MODELS WITH ACQUIRED RESISTANCE TO ANTI-PD-1/PD-L1 THERAPIES

Cancer immunology research, 2022-08, Vol.10 (8), p.1013-1027

2022

Volltextzugriff (PDF)

Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway

Oncotarget, 2018-04, Vol.9 (30), p.21141-21155

2018

Volltextzugriff (PDF)

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding

Oncotarget, 2017-09, Vol.8 (42), p.72818-72834

2017

Volltextzugriff (PDF)

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells

Pharmacology, 2018-01, Vol.102 (3-4), p.161-168

2018

Volltextzugriff (PDF)

Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models

European journal of medicinal chemistry, 2018-10, Vol.158, p.405-413

2018

Volltextzugriff (PDF)

Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies

mAbs, 2015-01, Vol.7 (1), p.192-198

2015

Volltextzugriff (PDF)

Deoxycholic acid derivatives as inhibitors of P-glycoprotein-mediated multidrug efflux

Steroids, 2016-12, Vol.116, p.5-12

2016

Volltextzugriff (PDF)

Synthesis of New Steroidal Inhibitors of P‑Glycoprotein-Mediated Multidrug Resistance and Biological Evaluation on K562/R7 Erythroleukemia Cells

Journal of medicinal chemistry, 2015-02, Vol.58 (4), p.1832-1845

2015

Volltextzugriff (PDF)

Progesterone–adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: Design, synthesis, characterization and biological evaluation

Steroids, 2012-10, Vol.77 (12), p.1177-1191

2012

Volltextzugriff (PDF)

Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells

Molecular cancer therapeutics, 2011-02, Vol.10 (2), p.303-312

2011

Volltextzugriff (PDF)

β3-Tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway

Cell motility and the cytoskeleton, 2009-07, Vol.66 (7), p.378-388

2009

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(33)
Berichte
(1)

Sprache

Englisch
(34)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity

A heavy metal baseline score predicts outcome in acute myeloid leukemia

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform

Antimitotic and Antiproliferative Activities of Chalcones: Forward Structure–Activity Relationship

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy

Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

Characterization of T‐DM1‐resistant breast cancer cells

Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability

Structure–activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

Proof of Concept: Protein Delivery into Human Erythrocytes Using Stable Cavitation

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells

ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells

IN VIVO SYNGENEIC TUMOR MODELS WITH ACQUIRED RESISTANCE TO ANTI-PD-1/PD-L1 THERAPIES

Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding

Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells

Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models

Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies

Deoxycholic acid derivatives as inhibitors of P-glycoprotein-mediated multidrug efflux

Synthesis of New Steroidal Inhibitors of P‑Glycoprotein-Mediated Multidrug Resistance and Biological Evaluation on K562/R7 Erythroleukemia Cells

Progesterone–adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux: Design, synthesis, characterization and biological evaluation

Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells

β3-Tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway

Aktive Filter

Suchergebnisse filtern